Member Info for fretfree

There was some press coverage in the UK press over the weekend I think (Daily Mail? There was a link earlier in the chat)

I doubt the answer is so simple. There are always multiple factors at play. In my view, the key is to understand how SAR is different, but be mindful of the mentality of traders and investors, and the machinations of the market.

It is an interesting observation, and I also note that the current prices of many of those shares are now very different -
NCYT 7p to 1210p in 2020 - 71m - now 347p
ODX 7p to 126p in 2020 - 183m - now 74p
AVCT 14p – 215p in 2020 - 253m - now 259p
SNG 6p to 240p in 2020 - 200m - now 154p
HEMO 1p to 15p in 2020 - 980m - now 2.10p
PYC 1.5p to 10.5p in 2020 - 97m - now 6.6p
YGEN 7p- 24p in 2020 - 723m - now 14p
N4P 2p to 16p in 2020 - 181m - now 8.75p
VAL 6p to 60p in 2020 - 65m - now 18.25p

So the only one that has gone up is AVCT, and all the others have reduced considerably. I don't have any knowledge about these companies so would just make a couple of observations:
1. SAR is not a one-trick pony. The Covid stream is a side play to their main foci (albeit a very welcome one!) and there have been numerous posts in the past outlining the sheer diversity of diseases that SAR's work can potentially tackle. This would suggest greater sustainability of shareprice.
2. AIM is super volatile. We all know that. But the above does suggest that time in analysis of one's own exit strategy is time well spent.

Is anyone invested in / know about the above companies and understand why AVCT has bucked the trend, and whether there are any important lessons for expectations for SAR?

GLA and fingers crossed for this week.

Utah - It's interesting that you are hoping for an RNS to sustain the rise. (ok, obviously with a big caveat here of what is in the RNS.....) do you think though that there could be a slight retrace after an RNS, based on the adage of "buy on rumour, sell on fact"? That is a little of what we have seen over the past years. For me, the potential value of this share (which I surmise from all the fab research on this BB) is definitely much higher, but I wonder how much buyers are buying/selling based on analysis (BB company excepted!) and how much on following sentiment trends - which would suggest there is still a lot of volatility to come, especially if people confuse profit taking with reduced confidence.

And the spread is the tightest I've ever seen it!!

The terminology of a third wave is being used in South Africa. In Switzerland, there are some comments that the third wave started in early March (but is less than the second wave). Ditto for the third wave across the EU (and it is noticeable that the UK is back on the red list for Switzerland, France, Germany etc.). Several countries have been doing great re vaccinations, but clearly we need multi-pronged strategies. Fingers crossed for a positive result from the initial SAR trials.

Thanks Fadec. Can anyone help me understand what this means though, given that it is someone else (Innocare) not Sareum? Are we being left behind? Or do we benefit from this advance?

Thanks Andy. Fingers crossed for what tomorrow (and tomorrow's tomorrow etc.) brings.

Hi all,
Very exciting times!!! I'm a LTH, having bought in at a placing at 60p in 2013. I'm used to seeing PMEs but I don't recall seeing one that was still in place at the end of a day. Can anyone explain what this would mean first thing tomorrow morning? Will it just open late? GLA

Sorry - wrong bulletin board!!!!

Hi all,
Very exciting times!!! I'm a LTH, having bought in at a placing at 60p in 2013. I'm used to seeing PMEs but I don't recall seeing one that was still in place at the end of a day. Can anyone explain what this would mean first thing tomorrow morning? Will it just open late?

A useful summary on non-vaccine progress - https://apnews.com/article/health-science-coronavirus-80c3e03423c017876edf558c64d08769

https://jamanetwork.com/journals/jamapediatrics/fullarticle/2779182

"In this multinational cohort study of 2130 pregnant women in 18 countries, women with COVID-19 diagnosis were at increased risk of a composite maternal morbidity and mortality index. Newborns of women with COVID-19 diagnosis had significantly higher severe neonatal morbidity index and severe perinatal morbidity and mortality index compared with newborns of women without COVID-19 diagnosis."

Yet another argument for as many different solutions with low toxicity!

The spread has diminished dramatically this morning - a good sign for the expected opening market? I don't think I've ever seen it so small (2.44%)

Pills, patches and inhalers could be second line of defence in care homes.

https://www.thetimes.co.uk/article/pills-patches-and-inhalers-could-be-second-line-of-defence-in-care-homes-3h9znntt8

Many thanks for the explanation all!

Hi all. Another LTH here who is really appreciative of the analysis on this board. Can someone please explain briefly why it is so important to set a sell limit? I check daily so it would not be for fear of missing a stratospheric rise. It seems like there are other tactical reasons for doing this. Can anyone elucidate? Many thanks and GLA

Really sorry to hear your story Jack. I too got swept along, and have lost a lot on this. I would so like something to happen, but I fear we have seen the end of this.

Last Response Date 00:59 20/07/2017 for accepting/declining the offer. Iit would be after that if they have received sufficient take ups for the takeover (which now the company is on board I assume is the case)

Thanks both - that makes a huge amount of sense. Sadly I don't have a huge amount to invest, having backed a wrong horse a while ago that is still suspended (not WRN though!), but it definitely seems worth a purchase at these prices. I also saw a recommendation for it from a broker firm on Friday, which was anticipating an up to 30% upside within 6 months (and that is when it was at 235p). They analysed that SMEs would most likely need more strategic banking support to re-orientate to the new reality.